Skip to main content

Table 5 Proposed BE scoring system

From: Barrett’s oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux

Score

BE severity

0

Pathology report not available

1

Intestinal metaplasia (IM) on biopsy and endoscopic findings not seen in categories below

2

C1 or C0 M3 + IM

3

C2 or more, C0 M4 or more +IM

4

C3 or more

5

Low grade dysplasia (LGD)

6

High grade dysplasia (HGD) or T1a cancer